// App-Quantinova.ai

P2-11-16 : Prospective comparison of prognostic factors in patients starting a third line of chemotherapy for metastatic breast cancer: An ancillary study to the CirCe01 trial

Researchers

Presenter

  • Helissey C

Principal Investigators

  • Berger F

  • Guilhaume M-N

  • Bidard F-C

  • Mauborgne C

  • Bouleuc C

  • Rodrigues M

  • Beuzeboc P

  • Cottu P

  • Dieras V

  • Mignot L

  • Pierga J-Y

Medical Centers

  • Institut Curie, Paris Cedex, France

  • INSERM, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Lymphocytopenia

  • Solid malignancies

Biomarkers

  • Carcinoembryonic antigen

  • Circulating tumor cells

  • Human albumin

  • Lactate dehydrogenase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved